Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Personalized Cancer Treatment Market Size Likely To Evolve From 2025 Through 2034?
The market size for personalized cancer treatment has seen rapid expansion in recent years. It is projected to increase from $181.55 billion in 2024 to $200.98 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. The expansion observed historically is attributable to developments in genomics and molecular biology, a rise in cancer prevalence, increased adoption of personalized medicine, greater awareness regarding cancer treatment choices, and enhanced technologies for cancer diagnostics and monitoring.
The personalized cancer treatment market is projected to experience swift expansion over the coming years. This market is anticipated to reach $301.14 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. Factors driving this growth during the forecast period include the widening application of targeted therapies, progress in AI and machine learning for planning treatments, increased funding for cancer research, a rising need for precision medicine, and the discovery of novel biomarkers for individualized therapies. Key trends identified for the forecast period encompass a surge in the utilization of combination therapies, greater integration of digital health technologies, an increase in the uptake of liquid biopsy methods, a broader range of immunotherapy choices, and a heightened emphasis on care models centered around patients.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19135&type=smp
Which Drivers Are Shaping The Personalized Cancer Treatment Industry’s Market Share?
The personalized cancer treatment market is projected to grow as cancer prevalence continues to rise. This increase in cancer cases is largely attributed to longer life expectancies, leading to more individuals reaching an age where cancer is more common, combined with heightened exposure to risk factors such as tobacco, alcohol, and obesity. Personalized cancer treatments offer targeted and effective therapies for managing diverse cancer types and stages, and this escalating burden stimulates investment and innovation within precision medicine, aiming to enhance patient outcomes through customized treatment plans. For instance, in February 2024, the World Health Organization, a Switzerland-based United Nations agency dedicated to global health and safety, projected a significant rise in the global cancer burden, with an expected 77% increase in new cancer cases, reaching over 35 million by 2050 compared to 20 million in 2022. Thus, the growing prevalence of cancer is propelling the personalized cancer treatment market forward.
What Are The Leading Segments Analyzed In The Personalized Cancer Treatment Market?
The personalized cancer treatmentmarket covered in this report is segmented –
1) By Treatment Type: Targeted Therapy; Immunotherapy; Hormone Therapy; Chemotherapy; Radiation Therapy; Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing; Liquid Biopsy; Immunohistochemistry; In Situ Hybridization; Biomarker Testing; Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Other Cancer Types
4) By End-Users: Hospitals And Clinics; Research Institutes; Other End Users
Subsegments:
1) By Targeted Therapy: Monoclonal Antibodies; Small Molecule Inhibitors; Angiogenesis Inhibitors; Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors; CAR T-Cell Therapy; Cancer Vaccines; Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens; Aromatase Inhibitors; Progestins; LHRH Agonists
4) By Chemotherapy: Alkylating Agents; Antimetabolites; Anthracyclines; Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Brachytherapy; Radioimmunotherapy; Stereotactic Radiosurgery (SRS)
6) By Other Treatment Types: Gene Therapy; Stem Cell Transplantation; Metabolic Therapy; Nanomedicine
Which Competitive Trends Are Defining The Personalized Cancer Treatment Market Structure?
Leading companies within the personalized cancer treatment market are concentrating on developing advanced solutions, such as artificial intelligence (AI)-powered multimodal immune profile algorithmic tests, to forecast patient reactions to immunotherapy and refine individualized treatment strategies. An AI-driven multimodal immune profile algorithmic test scrutinizes multiple data types, including genomic, transcriptomic, and clinical indicators, to evaluate a patient’s immune status and predict their response to immunotherapy, thereby assisting in patient stratification and guiding personalized cancer treatments. For instance, in July 2024, Tempus AI, Inc., a US-based health technology company, introduced its AI-enabled multimodal immune profile algorithmic test (IPS), marking its first offering in the immunotherapy diagnostics field. The test, available for research use only (RUO), assesses a spectrum of immunotherapy-related biomarkers to generate a score that helps predict patient response to immunotherapy, supporting personalized cancer treatment. These AI-powered immunotherapy-focused diagnostics enhance patient grouping and treatment selection in oncology.
Which Global Market Leaders Are Shaping The Future Of The Personalized Cancer Treatment Sector?
Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/personalized-cancer-treatment-global-market-report
How Do Regional Market Performances Compare Within The Personalized Cancer Treatment Industry?
North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Personalized Cancer Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=19135&type=smp
Browse Through More Reports Similar to the Global Personalized Cancer Treatment Market 2025, By The Business Research Company
Cancer Immunotherapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report
Solid Tumor Cancer Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report
Endometrial Cancer Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/endometrial-cancer-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model